| Stem definition | Drug id | CAS RN |
|---|---|---|
| 4346 | 7727-43-7 |
| Molecule | Description |
|---|---|
|
Synonyms:
|
A compound used as an x-ray contrast medium that occurs in nature as the mineral barite. It is also used in various manufacturing applications and mixed into heavy concrete to serve as a radiation shield.
|
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| No adverse event | 116.03 | 48.89 | 28 | 238 | 41377 | 63447379 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| No adverse event | 70.80 | 47.30 | 16 | 100 | 22911 | 34933904 |
| Aspiration | 62.83 | 47.30 | 13 | 103 | 12181 | 34944634 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Aspiration | 76.20 | 36.88 | 18 | 373 | 20140 | 79723857 |
| Urticaria | 59.55 | 36.88 | 25 | 366 | 185176 | 79558821 |
| Barium impaction | 44.92 | 36.88 | 4 | 387 | 0 | 79743997 |
None
| Source | Code | Description |
|---|---|---|
| ATC | V08BA01 | VARIOUS CONTRAST MEDIA X-RAY CONTRAST MEDIA, NON-IODINATED Barium sulfate containing X-ray contrast media |
| FDA MoA | N0000010258 | X-Ray Contrast Activity |
| MeSH PA | D003287 | Contrast Media |
| MeSH PA | D064907 | Diagnostic Uses of Chemicals |
| FDA EPC | N0000180185 | Radiographic Contrast Agent |
| CHEBI has role | CHEBI:37338 | contrast media |
None
None
None
None
None
None
None
| ID | Source |
|---|---|
| 4018191 | VUID |
| N0000146525 | NUI |
| D02052 | KEGG_DRUG |
| 4018191 | VANDF |
| C0004754 | UMLSCUI |
| CHEBI:133326 | CHEBI |
| CHEMBL2105897 | ChEMBL_ID |
| D001466 | MESH_DESCRIPTOR_UI |
| DB11150 | DRUGBANK_ID |
| 25BB7EKE2E | UNII |
| 24414 | PUBCHEM_CID |
| 1331 | RXNORM |
| 4245 | MMSL |
| 740 | MMSL |
| d01445 | MMSL |
| 001100 | NDDF |
| 25419009 | SNOMEDCT_US |
| 396014007 | SNOMEDCT_US |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| E-Z-Disk | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10361-778 | TABLET | 700 mg | ORAL | Unapproved drug other | 17 sections |
| E-Z-Disk | HUMAN PRESCRIPTION DRUG LABEL | 1 | 10361-778 | TABLET | 700 mg | ORAL | Unapproved drug other | 17 sections |
| Varibar Thin Liquid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-105 | POWDER, FOR SUSPENSION | 0.81 g | ORAL | NDA | 13 sections |
| Varibar Thin Liquid | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-105 | POWDER, FOR SUSPENSION | 0.81 g | ORAL | NDA | 13 sections |
| Varibar Nectar | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-115 | SUSPENSION | 400 mg | ORAL | NDA | 14 sections |
| Varibar Nectar | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-116 | SUSPENSION | 400 mg | ORAL | NDA | 14 sections |
| Varibar Thin Honey | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-121 | SUSPENSION | 400 mg | ORAL | NDA | 14 sections |
| Varibar Honey | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-122 | SUSPENSION | 400 mg | ORAL | NDA | 14 sections |
| Varibar Pudding | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-125 | PASTE | 400 mg | ORAL | NDA | 22 sections |
| Varibar Pudding | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-125 | PASTE | 400 mg | ORAL | NDA | 22 sections |
| ENTERO Vu 24% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-145 | SUSPENSION | 240 mg | ORAL | NDA | 20 sections |
| ENTERO Vu 24% | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-146 | SUSPENSION | 240 mg | ORAL | NDA | 20 sections |
| Liquid Polibar Plus | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-167 | SUSPENSION | 1.05 g | ORAL | Unapproved drug other | 19 sections |
| Liquid Polibar Plus | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-168 | SUSPENSION | 1.05 g | ORAL | Unapproved drug other | 19 sections |
| E-Z-Paque | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-186 | SUSPENSION | 0.60 g | ORAL | NDA | 14 sections |
| E-Z-Paque | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-187 | SUSPENSION | 0.60 g | ORAL | NDA | 14 sections |
| Readi-Cat 2 Berry Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-711 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 Banana Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-722 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-724 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 Berry Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-741 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 Banana Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-742 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-744 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 Creamy Vanilla Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-746 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| Readi-Cat 2 Mochaccino Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-747 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| E-Z-Paque | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-750 | POWDER, FOR SUSPENSION | 960 mg | ORAL | NDA | 14 sections |
| E-Z-Paque | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-750 | POWDER, FOR SUSPENSION | 960 mg | ORAL | NDA | 14 sections |
| Readi-Cat 2 Creamy Vanilla Smoothie | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-756 | SUSPENSION | 20 mg | ORAL | NDA | 15 sections |
| E-Z-HD | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-764 | POWDER, FOR SUSPENSION | 980 mg | ORAL | NDA | 15 sections |
| E-Z-HD | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-764 | POWDER, FOR SUSPENSION | 980 mg | ORAL | NDA | 15 sections |
| E-Z-Paste | HUMAN PRESCRIPTION DRUG LABEL | 1 | 32909-770 | CREAM | 0.60 g | ORAL | Unapproved drug other | 19 sections |